Glycomet: Advanced Blood Glucose Management for Type 2 Diabetes
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 180 | $0.24 | $43.17 (0%) | 🛒 Add to cart |
| 270 | $0.21 | $64.76 $57.23 (12%) | 🛒 Add to cart |
| 360 | $0.20
Best per pill | $86.34 $71.28 (17%) | 🛒 Add to cart |
Similar products
Glycomet is a widely prescribed oral antidiabetic medication containing metformin hydrochloride, designed to help manage blood sugar levels in individuals with type 2 diabetes. As a first-line therapy, it works by decreasing hepatic glucose production and improving insulin sensitivity in peripheral tissues. Glycomet is often recommended in conjunction with diet and exercise to achieve optimal glycemic control and reduce the risk of diabetes-related complications. Its efficacy, safety profile, and long-standing clinical use make it a cornerstone in diabetes treatment protocols worldwide.
Features
- Contains metformin hydrochloride as the active ingredient
- Available in various strengths: 500 mg, 850 mg, and 1000 mg tablets
- Film-coated for easier swallowing and reduced gastrointestinal irritation
- Manufactured under strict quality control and pharmaceutical standards
- Often available in extended-release formulations for once-daily dosing
Benefits
- Effectively lowers and stabilizes blood glucose levels throughout the day
- Reduces the risk of long-term diabetic complications such as neuropathy, retinopathy, and nephropathy
- May contribute to modest weight loss or weight neutrality, unlike some other antidiabetic agents
- Lowers hemoglobin A1c (HbA1c) levels, supporting long-term metabolic health
- Improves lipid profiles by reducing triglycerides and LDL cholesterol
- May offer cardiovascular protective benefits in certain patient populations
Common use
Glycomet is primarily indicated for the management of type 2 diabetes mellitus in adults and children over 10 years of age. It is used as monotherapy or in combination with other oral antidiabetic agents or insulin when glycemic targets are not achieved with lifestyle modifications alone. It may also be used off-label for conditions such as polycystic ovary syndrome (PCOS) to address insulin resistance and support metabolic and reproductive health.
Dosage and direction
The dosage of Glycomet should be individualized based on the patient’s glycemic control, renal function, and tolerance. The usual starting dose for adults is 500 mg once or twice daily, or 850 mg once daily, taken with meals to minimize gastrointestinal side effects. Dosage may be gradually increased at weekly intervals, up to a maximum of 2000–2550 mg per day, divided into two or three doses. For extended-release formulations, the typical starting dose is 500 mg once daily with the evening meal, titrated up to a maximum of 2000 mg daily. Dosage adjustments are necessary in patients with renal impairment. Always follow the prescribing physician’s instructions.
Precautions
Before taking Glycomet, inform your healthcare provider if you have a history of kidney disease, liver impairment, heart failure, or metabolic acidosis. Avoid excessive alcohol consumption, as it may increase the risk of lactic acidosis. Glycomet may affect vitamin B12 absorption; periodic monitoring of B12 levels is advised. Use with caution in elderly patients and those undergoing radiologic studies involving iodinated contrast materials, as temporary discontinuation may be required. Hydration is important to reduce renal risks.
Contraindications
Glycomet is contraindicated in patients with severe renal impairment (eGFR below 30 mL/min/1.73m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis. It should not be used in patients with hypersensitivity to metformin or any component of the formulation. Avoid use in conditions predisposing to renal dysfunction, such as dehydration, severe infection, or shock. Glycomet is not indicated for type 1 diabetes mellitus.
Possible side effects
Common side effects include gastrointestinal disturbances such as nausea, vomiting, diarrhea, abdominal discomfort, and a metallic taste. These often subside with continued use. Rare but serious side effects may include lactic acidosis (symptoms include muscle pain, breathing difficulties, dizziness, and slow heartbeat), vitamin B12 deficiency, and hypoglycemia when used with other antidiabetic drugs. Report any unusual symptoms to a healthcare provider promptly.
Drug interaction
Glycomet may interact with several medications. Cimetidine, furosemide, nifedipine, and cationic drugs may increase metformin plasma levels. Concomitant use with sulfonylureas, insulin, or other glucose-lowering agents may enhance hypoglycemic effects. Drugs such as corticosteroids, diuretics, and phenothiazines may reduce its efficacy. Always inform your doctor about all prescription, over-the-counter, and herbal products you are taking.
Missed dose
If a dose is missed, take it as soon as remembered unless it is almost time for the next dose. Do not double the dose to make up for a missed one. Resume the regular dosing schedule. Consistent adherence is important for maintaining glycemic control.
Overdose
Overdose of Glycomet may lead to hypoglycemia or lactic acidosis. Symptoms of hypoglycemia include sweating, trembling, blurred vision, and confusion. Lactic acidosis may present with vomiting, abdominal pain, and hyperventilation. In case of suspected overdose, seek immediate medical attention. Treatment is supportive and may include glucose administration for hypoglycemia and hemodialysis for metformin removal in severe cases.
Storage
Store Glycomet tablets at room temperature (15–30°C), in a dry place, away from direct light and moisture. Keep the container tightly closed and out of reach of children. Do not use beyond the expiration date printed on the packaging.
Disclaimer
This information is for educational purposes only and does not replace professional medical advice. Always consult a qualified healthcare provider for diagnosis, treatment decisions, and personalized recommendations. Do not initiate, adjust, or discontinue medication without medical supervision.
Reviews
Glycomet has been extensively studied and is highly regarded in clinical practice for its efficacy in managing type 2 diabetes. Many patients report improved glycemic control and quality of life. Some users note initial gastrointestinal side effects, which often diminish over time. Healthcare professionals appreciate its well-established safety profile and flexibility in combination therapy. Individual experiences may vary; discuss any concerns with your prescribing physician.